Statement Of Cash Flows [Abstract]

Transgene - Filing #881725

Concept 2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Adjustments for finance income (cost)
3 989 EUR
6 762 EUR
Cash flows from (used in) operations before changes in working capital
19 145 EUR
20 061 EUR
Adjustments for depreciation expense
2 521 EUR
1 786 EUR
Cash flows from (used in) financing activities [abstract]
Payments for share issue costs
787,000 EUR
- EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.